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Abstract: The short-term safety and efficacy of intracorneal ring segment (ICRS) implantation in
keratoconus eyes of children are investigated in this study. A retrospective interventional case
series study including a total of 33 keratoconus eyes (age 8 to 17 years) that had undergone ICRS
(Keraring segments, Mediphacos) implantation was conducted. Information about visual, refractive,
pachymetric, corneal topographic and aberrometric, and corneal endothelial changes during a 3-
month follow-up were extracted and analysed. A significant improvement was observed in logMAR
corrected distance visual acuity (p = 0.005), combined with a statistically significant reduction in
keratometric readings (p < 0.001). A reduction in the magnitude of corneal astigmatism of ≥1 D
was observed in 52.8% of eyes. No significant changes were observed in corneal endothelial density
(p = 0.317). Significant changes were found in the anterior vertical coma component (p = 0.002) as
well as in the spherical aberration of the posterior corneal surface (p = 0.004). Only two relevant
complications were described: one corneal microperforation with penetration of the ring segment
into the anterior chamber (1 eye, 2.8%), and a case of ring extrusion (1 eye, 2.8%). ICRS implantation
in children keratoconus eyes allows a reduction of corneal astigmatism, irregularity, and aberrations,
leading to a significant visual improvement.
Keywords: keratoconus; intracorneal ring segments; intrastromal ring segments; Keraring;
corneal aberrations
1. Introduction
Keratoconus is a degenerative corneal disease that is commonly manifested during
puberty, with the possibility of progressing until the third or fourth decade of life [1].
This condition is characterized by a significant corneal thinning, corneal protrusion and
induction of myopic astigmatism, with development of corneal opacity and hydrops in
some cases [1]. In children, keratoconus is one of the most frequent causes leading to
corneal transplantation with rates up to 20% [2,3]. It should be considered that keratoconus
in children are commonly more severe, with fast progression and high incidence of pruritus
associated [4–6]. Furthermore, children often manipulate their eyes with their fingers,
and the medical accompaniment and care of family members in avoiding the factors that
trigger the allergy is not always adequate. This mechanical stress on the cornea is a factor
that may promote the progression and development of the disease [7].
Although keratoplasty is a potential solution in the most advanced keratoconus cases,
both penetrating and deep lamellar keratoplasty are not exempt from complications such
as rejection of the donor button, vascularization and infectious diseases [8]. In children,
postoperative controls become more complex and with inadequate collaboration for suture
removal, as additionally children are more prone to suffer traumas that can affect the
integrity of the eye [8–10]. For this reason, the viability of other keratoconus treatment
options in children are being investigated, such as corneal collagen crosslinking (CXL) [11].
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Despite the proved efficacy and safety of intracorneal ring segments (ICRS) for the man-
agement of keratoconus [12], there are few studies evaluating the potential usefulness of
this treatment option in children [13,14]. The aim of the current study was to evaluate the
safety and efficacy of ICRS implantation in keratoconus in children, evaluating changes in
visual acuity, refraction, pachymetry, corneal topography and aberrometry, and corneal
endothelial density during a 3-month follow-up.
2. Materials and Methods
2.1. Patients
Retrospective interventional case series including a total of 33 keratoconus eyes
(21 men and 12 women) that had undergone ICRS implantation using the femtosecond laser
technology for the creation of the tunnels. All cases included were treated and followed at
Clinica de Ojos Larco Vision (Quito, Ecuador), with all surgeries performed in the period
from May 2015 to July 2018. Inclusion criteria were keratoconus diagnosis according to
the standard criteria that consider the presence of the following signs: anterior corneal
topographic asymmetric bowtie pattern, KISA ≥ 100, and one or more biomicroscopic
keratoconus signs, such as Fleischer ring, significant corneal thinning, Vogt striae, con-
ical protrusion on the cornea at the apex or anterior stromal scar [15]. Previous ocular
surgery, corneal opacity affecting the visual axis and any other active ocular disease were
considered as exclusion criteria. The study was conducted following the tenets of the
Declaration of Helsinki and was approved by the ethics committee of the institution where
the investigation was developed.
2.2. Clinical Examinations
A complete preoperative ophthalmological examination was performed in all cases in-
cluding measurement of uncorrected (UDVA) and corrected distance visual acuity (CDVA),
autorefraction (KR-800 Topcon Medical System), cycloplegic and manifest refraction, slit
lamp evaluation of the anterior segment, fundus evaluation, pupillometry, specular mi-
croscopy for corneal endothelial cell density analysis (Konan Cell Check, Konan Medical
USA Inc., Irvine, CA, USA) and corneal topographic, pachymetric and aberrometric evalu-
ation with the Scheimpflug imaging-based system Pentacam (Oculus Optikgerate GmbH,
Wetzlar, Germany). Postoperative examinations were performed the day after surgery,
at 1 week, 1 month, and 3 months after surgery. In the last postoperative visit, a complete
eye examination identical to the preoperative exam was performed. The importance of not
rubbing the eyes and maintaining the anti-allergic treatment was remarked to all patients
and their relatives, with the additional recommendation of attending to eye controls every
3 months.
All patients received indications and anti-allergic treatment prior to surgery and it
was maintained indefinitely.
2.3. Surgery
All surgical procedures were performed by the same experienced surgeon (PL) un-
der topical anaesthesia (combination of tetracaine 0.1% and oxybuprocaine 0.4%, Alcon,
Fort Worth, TX, USA). The femtosecond laser platform FS 200 (Alcon Laboratories, Inc,
Fort Worth, TX, USA) was used to create the corneal incision and tunnels. The tunnels
were created at 70% of corneal depth ensuring that at least 100 µm of corneal tissue was
present under the tunnel. Keraring segments (Mediphacos, Belo Horizonte, Brazil) were
implanted in all cases, with a selection of the number of segments to implant as well
as their diameter (SI5 or SI6), arc length and thickness according to the manufacturer’s
nomogram and the scotopic pupil size measured. Table 1 summarizes the parameters
used in the femtosecond laser platform for the different type of ring segments implanted.
Topical antibiotics (Moxifloxacin 0.3%, Alcon Laboratories Inc., Fort Worth, TX, USA) were
instilled at the time of implanting ICRS and at the end of the surgery. No stitches and/or
therapeutic contact lenses were needed. A plastic protector was placed in the implanted
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eye to avoid the manipulation of the operated eye. Topical tobramycin 0.3% combined with
sodium dexamethasone phosphate 0.1% (Tobradex, Alcon Laboratories Inc, Fort Worth,
TX, USA) was instilled in the operated eye 4 times per day for 15 days.
Table 1. Parameters used in the femtosecond laser platform for the different type of ring segments implanted.
Parameters SI5 (90◦–120◦–160◦) SI5 (210◦) SI6 (90◦–120◦–160◦) SI6 (210◦) 355◦
Inner diameter 5.0 mm 5.0 mm 5.8 mm 5.8 mm 5.2 mm
Outer diameter 5.9 mm 6.0 mm 7.0 mm 7.1 mm 6.6 mm
Incision 1.4 × 1.4 mm 1.4 × 1.4 mm 1.5 × 1.5 mm 1.5 × 1.5 mm 1.5 × 1.5 mm
Depth
75% of the thinnest
pachymetry in a
5-mm zone
75% of the thinnest
pachymetry in a
5-mm zone
75% of the thinnest
pachymetry in a
6-mm zone
75% of the thinnest
pachymetry in a
6-mm zone




The statistical power associated to the sample size selected was calculated using
the online calculator, https://www.imim.cat/ofertadeserveis/software-public/granmo/.
Assuming a paired test in a same group for detecting significant differences in CDVA,
the statistical power was 84.0% for the detection of a minimum difference of −0.16 logMAR
(minimum change in CDVA observed at 3 months postoperatively), considering an alpha
error of 0.05, the sample of 33 eyes, and the standard deviation of differences in CDVA at
3 months after surgery (0.31 logMAR).
Statistical analyses were performed with a commercially available software package
(SPSS for Mac, v. 20.0; IBM Corporation, Armonk, NY, USA). Normality of data samples
was evaluated by means of the Kolmogorov-Smirnov test. When parametric analysis was
possible, the Student t test for paired data was used for comparisons between preoperative
and postoperative visits, whereas the Wilcoxon ranked sum test was applied to assess the
significance of such differences when parametric analysis was not possible. The Pearson
or Spearman correlation coefficient was used to assess the level of correlation between
preoperative corneal astigmatism and the clinical outcomes obtained depending if the
condition of normality could be assumed or not. For all statistical tests, a p-value of less
than 0.05 was considered as statistically significant.
3. Results
3.1. Description of the Sample
A total of 33 eyes of 33 patients with mean age of 14.9 years (SD: 1.9, median: 15.0,
range: 8 to 17 years) were enrolled. The sample was comprised of 21 males (63.6%) and
12 females (36.4%). A total of 15 right (41.7%) and 21 left eyes (58.3%) were included.
The model of ring segments SI5 was implanted in a total of 16 eyes (44.4%), whereas a
total of 20 eyes (55.6%) were implanted with the SI6 ring segments. In all cases except in
12 eyes, two ring segments were implanted (a total of 60 ring segments), with the following
distribution in terms of arc length: 90◦ in 11 eyes (11/60, 18.3%), 120◦ in 18 eyes (18/60,
30.0%), 150◦ in 15 eyes (15/60, 25.0%), 160◦ in 9 eyes (9/60, 15.0%), 210◦ in 4 eyes (4/60,
6.7%), and 340◦ in 3 eyes (3/60, 5%). Concerning ring segment thickness, the distribution
of cases was as follows: 150 µm in 3 eyes (3/60, 5%), 200 µm in 14 eyes (14/60, 23.3%),
250 µm in 12 eyes (12/60, 20.0%), and 300 µm in 31 eyes (31/60, 51.7%).
3.2. Visual, Refractive, and Corneal Topographic Changes
Table 2 summarizes the preoperative and postoperative visual, refractive and corneal
tomographic data obtained in the analyzed sample. A reduction in magnitude was ob-
served in sphere, cylinder, and spherical equivalent (SE) in most patients, but these changes
did not reach statistical significance (p ≥ 0.066). However, a significant improvement was
also observed in logMAR CDVA (p = 0.005). Concerning keratometric readings, a sta-
tistically significant reduction was observed in K1 (p = 0.001), K2 (p < 0.001), and KM
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(p < 0.001). Consequently, a significant reduction was observed in the magnitude of corneal
astigmatism (p < 0.001), with 11.1% (4/36) and 69.2% (18/26) of eyes with magnitude of
anterior corneal astigmatism of 3 D or less before and 3 months after surgery, respectively
(Figure 1). A total of 52.8% (19/36) of eyes showed a reduction in the magnitude of an-
terior corneal astigmatism of 1 D or more. A very strong and significant correlation was
found between the preoperative magnitude of anterior corneal astigmatism and the change
induced at 3 months after surgery in anterior corneal astigmatism (r = −0.903, p < 0.001)
(Figure 2). Concerning central pachymetry, no significant changes were observed with
surgery (p = 0.647).
Table 2. Summary of preoperative and postoperative visual, refractive and corneal tomographic data
in the analyzed sample. In each box, the mean (standard deviation) is provided and below the median
(range). The corresponding p-values for the comparison between preoperative and postoperative
visits are shown for each parameter evaluated.
Mean (SD) Preoperative Postoperative p-Value
Median (Range)
Sphere (D) −3.17 (4.82) −2.75 (5.76) 0.655−1.38 (−20.50 to 0.75) 0.00 (−15.75 to 3.00)
Cylinder (D) −5.02 (2.34) −1.70 (2.11) 0.066−4.63 (−9.75 to −1.50) −0.50 (−5.00 to 0.00)
Spherical equivalent (D) −5.68 (5.17) −3.60 (6.45) 0.066−4.00 (−25.38 to −0.25) 0.00 (−18.25 to 0.62)
LogMAR CDVA 0.86 (0.67) 0.30 (0.32) 0.0050.70 (0.00 to 3.00) 0.29 (0.00 to 1.00)
K1 (D)
49.53 (5.48) 48.28 (5.35)
0.00147.90 (42.20 to 63.70) 47.45 (40.20 to 59.40)
K2 (D)
55.38 (5.56) 50.98 (5.71)
<0.00154.25 (46.90 to 67.70) 49.50 (43.50 to 65.90)
KM (D)
52.27 (5.39) 49.58 (5.46)
<0.00150.90 (45.60 to 65.70) 48.35 (42.30 to 61.50)
Anterior corneal astigmatism (D) 5.85 (2.38) 2.70 (1.56) <0.0015.65 (1.80 to 10.40) 2.45 (0.70 to 8.20)
CCT (µm)
451.42 (49.86) 445.77 (59.71)
0.647460.50 (335 to 539) 465.00 (285 to 536)
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Figure 1. Preoperative and postoperative distribution of the magnitude of corneal astigmatism in the
analyzed sample.
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3.3. Corneal Aberrometric Changes
Table 3 summarizes the preoperative and postoperative corneal aberrometric data
obtained in the analyzed sample. Statistically significant changes were found in the vertical
coma component of the anterior corneal surface (p = 0.002) as well as the spherical aberra-
tion of the posterior corneal surface (p = 0.004). No significant changes were observed in the
remaining aberrometric components (p ≥ 0.200). A poor lthough significant orrelation
was found between preoperative coma RMS and the change induced in this paramet r
with surgery (r = −0.443, = 0.024). No correlation was found betw en the preoperative
magnitud of spherical aberration and the change induced in this parameter with surgery
(r = −0.185, p = 0.336).
3.4. Complications
Concerning safety and complications, only two relevant complications were described,
one corneal microperforation with penetration of the ring segment into the anterior chamber
(1 eye, 2.8%), and a case of ring extrusion (1 eye, 2.8%) (Figure 3). No significant changes
were found in corneal endothelial density (p = 0.317), with mean preoperative and 3-month
postoperative values of 2795.08 cell/mm2 (SD: 304.53, median: 2857, range: 1869 to 3205)
and 2624.50 cell/mm2 (SD: 512.42, median: 2822, range: 1869 to 2822), respectively.
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Table 3. Summary of preoperative and postoperative corneal aberrometric data in the analyzed
sample. The corresponding p-values for the comparison between preoperative and postoperative
visits are shown for each parameter evaluated.
Mean (SD) Preoperative Postoperative p-Value
Median (Range)
Anterior corneal surface:
Z3−1 (µm) −0.89 (1.16) −1.00 (1.48) 0.002
−0.78 (−4.28 to 1.70) −1.04 (−3.98 to 2.74)
Z31 (µm) −0.08 (1.74) 0.02 (1.23) 0.395
0.16 (−5.84 to 3.04) 0.17 (−1.90 to 3.14)
Coma RMS (µm) 1.94 (1.15) 1.88 (1.02) 0.485
1.77 (0.17 to 6.21) 1.62 (0.49 to 3.98)
Z40 (µm) −0.99 (0.94) −0.97 (1.07) 0.713
−0.89 (−3.82 to 1.18) −0.90 (−4.04 to 0.60)
Posterior corneal surface:
Z3−1 (µm) 0.24 (0.33) 0.21 (0.34) 0.617
0.25 (−0.37 to 1.19) 0.18 (−0.43 to 1.09)
Z31 (µm) 0.01 (0.41) −0.01 (0.48) 0.909
−0.08 (−0.70 to 1.32) −0.01 (−1.04 to 0.90)
Coma RMS (µm) 0.50 (0.29) 0.54 (0.30) 0.501
0.43 (0.12 to 1.56) 0.49 (0.04 to 1.24)
Z40 (µm) 0.14 (0.18) 0.24 (0.19) 0.004
0.11 (−0.15 to 0.65) 0.21 (−0.21 to 0.61)
Total cornea:
Z3−1 (µm) −0.75 (1.05) −0.94 (1.53) 0.431
−0.69 (−3.80 to 1.66) −0.97 (−4.78 to 2.78)
Z31 (µm) −0.04 (1.59) 0.02 (1.00) 0.454
0.32 (−5.49 to 2.89) 0.10 (−1.68 to 2.72)
Coma RMS (µm) 1.72 (1.08) 1.73 (1.06) 0.381
1.48 (0.22 to 5.76) 1.35 (0.36 to 4.79)
Z40 (µm) −0.96 (1.61) −0.71 (1.03) 0.200
−0.52 (−8.82 to 1.54) −0.72 (−3.75 to 0.79)
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Figure 3. Graphic summary of changes occurring in the eye suffering a ring extrusion. Up: topographic modifications
achieved with the ring segment (left: post, center: pre, right: change), showing below the corresponding slit lamp images.
Down: topographic changes during 30 days of follow-up after explanting the ring segment (left 30 days post-explantation,
middle: the same day after explantation, right: change).
4. Discussion
In the last two decades, advances in keratoconus management have been focused
on avoiding corneal transplantation [16]. Although the prognosis of keratoplasty has
been shown to be good in keratoconus, this procedure is more complex in children as the
cornea is thinner and less rigid compared to adults, with more significant inflammatory
reaction and more risks of infection and corneal graft rejection [10]. Several studies have
confirmed the validity of CXL [11] and contact lenses fitting of special designs, such as
scleral lenses [17], for the management of keratoconus, even in children [18–21]. Likewise,
some studies have shown the potential of the use of ICRS in keratoconus in children,
allowing a regularization of the corneal surface, an improvement of visual quality and even
an improvement in contact lens tolerance [13,14,22,23]. In most of the cases, this implan-
tation was combined with CXL [22,23]. The aim of the current study was to analyze the
short-term visual, refractive, and corneal aberrometric outcomes after ICRS implantation
for the management of keratoconus in a sample of children. Thus, the real effect of these
implants in this type of corneas can be clearly characterized and understood independently
if CXL is applied afterwards to obtain a better control of the progression of the disease.
Concerning the refractive outcomes, a reduction in magnitude was observed in sphere,
cylinder and SE in most of patients, but not reaching statistical significance in the overall
sample. This is consistent with the variability of ICRS outcomes reported in the peer-
reviewed literature according to the corneal topographic phenotypic profile and the level of
severity of the disease [24–26]. Recently, Sedaghat and colleagues [27] confirmed in adult
patients implanted with the same type of ICRS (KeraRing) that a greater difference between
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the preoperative uncorrected and corrected distance visual acuity and more coincidence
of the most elevated points in the two corneal surfaces on the elevation maps increased
the rate of successful outcome. Despite the non-statistically significant change in refrac-
tion, significant modifications were found in the current series in keratometric readings,
the magnitude of corneal astigmatism, and logMAR CDVA, as in previous series using the
same and other type of ICRS in adults and children [12–14]. Specifically, significant central
corneal flattening, reduction of magnitude of astigmatism and improvement of CDVA were
observed, with 52.8% of eyes showing a reduction in the magnitude of anterior corneal
astigmatism of 1 D or more. Heikal et al. [28] found in a sample of 20 adult keratoconus
eyes implanted with KeraRing using the femtosecond laser technology that mean LogMAR
CDVA improved from 0.85 ± 0.17 preoperatively to 0.26 ± 0.11 at 3 months postoperatively
(p = 0.001). Alfonso et al. [13] reported in a sample of 118 eyes of 88 children a change of
mean CDVA from 0.67 ± 0.37 logMAR preoperatively to a value of 0.37 ± 0.30 logMAR at
6 months after ICRS implantation. In the current series, a change from a mean preoperative
value of 0.86 ± 0.67 logMAR to a mean 3-month postoperative value of 0.30 ± 0.32 logMAR
was observed. Gharaibeh et al. [29] also reported a significant visual improvement after
KeraRing implantation in a sample of 55 eyes of adult patients, with a decrease in mean
keratometry from 51.83 ± 4.14 D preoperatively to 47.27 ± 3.68 D at 6 months after surgery
that is consistent with the keratometric change found in the current study.
The change induced at 3 months postoperatively in the magnitude of anterior corneal
astigmatism was strongly correlated with the preoperative magnitude of anterior corneal
astigmatism. This correlation was negative which indicated that less reduction of corneal
astigmatism was achieved in those cases with lower levels of baseline corneal toricity.
This suggests that no more undercorrection was present in cases of high levels of corneal
astigmatism. However, despite the greater astigmatic corrective effect achieved in very
toric corneas, the impact of potential misalignments of the meridian of correction is higher,
as demonstrated in previous series [30]. In any case, improvements in nomograms in the
last years have allowed the clinician to obtain more predictable outcomes by selecting a
more optimized position of ICRS, even in cases of high astigmatism [25,26].
The analysis of changes in corneal aberrations in the current series revealed that
statistically significant changes were found in the vertical coma component of the anterior
corneal surface as well as in the spherical aberration of the posterior corneal surface.
There was a trend to a reduction of primary coma RMS that did not reach statistical
significance, as has been reported in other studies evaluating the corneal aberrometric
outcomes after KeraRing implantation [31]. The main factor accounting for this finding
may be the great variability of corneal high order aberrations that was present in the sample
evaluated as cases with different levels of severity were included. A similar situation was
reported by Haddad et al. [32] when comparing the outcomes of two different types of ICRS,
being one of them KeraRing. It should be considered that corneal high order aberrations
increase with the level of severity [13], and the efficacy of ring segments is conditioned by
this aberrometric profile [31]. Possibly, significant changes in primary coma RMS would
have been detected if a larger sample would have been evaluated and subdivided by
severity groups. Indeed, Alfonso et al. [13] reported a statistically significant decrease in
coma-like RMS in a sample including 118 eyes from 88 pediatric patients undergoing ICRS
implantation. Besides primary coma, a significant change of primary spherical aberration
towards a more positive value was found as in previous series [31,32]. This finding is
consistent with the curvature change induced in the central part of the cornea (central
flattening vs. peripheral steepening), leading to a less prolate corneal configuration.
Finally, the safety of the procedure was confirmed with the gain of lines of CDVA and
the presence of only two relevant complications, a corneal microperforation with penetra-
tion of the ring segment into the anterior chamber and a ring extrusion. These complications
have been also reported in series with adult patients [12]. In our series, the microperfo-
ration occurred in a 13-year-old boy at 3 days after surgery. Due to eye rubbing, the ring
segment penetrated the anterior chamber and it was then explanted, with the implantation
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of ring segment of less arc length afterwards to avoid the contact with the compromised
area. The ring extrusion occurred in an 8-year-old girl implanted with a 340◦ ring seg-
ment and with association to a significant foreign body sensation (Figure 3). The ring
segment was fractioned manually by cutting one end and was re-inserted away from the
incision, disappearing the discomfort. This case presented a favourable evolution and
no topographic changes were observed in its follow-up of 31 months. In previous series
showing the results of ICRS in children, only one complication was reported in one case:
ring segment explantation 2 years after its implantation due to vascularization and corneal
thinning [23]. Concerning pachymetry and corneal endothelial density, no significant
changes were detected during the follow-up, confirming the safety of the procedure.
As limitations of the study, it should be noted that no validated questionnaires were
used to assess and characterize changes in symptomatology. This should be investigated
in future series evaluating the impact of ICRS implantation in children with keratoconus.
Likewise, the results of this technique in a longer follow-up period should be reported
to confirm the long-term safety of the procedure. Despite these limitations, this article
adds new information in terms of tomographic and corneal aberrometric changes to the
currently available peer-reviewed literature [13,14,33] about the clinical outcomes of ICRS
information in pediatric keratoconus.
5. Conclusions
In conclusion, the implantation of ICRS in children is a safe procedure, which is not
exempt from complications like the two reported cases, related to manipulation of the
eyes, despite having been warned not to do it and that they were solved without problems.
The case of the migration of the ICRS to the anterior chamber had a previous history of
micro perforation 3 months before the implantation of the ICRS. Possibly, the combination
with CXL is necessary in most cases to avoid keratoconus progression, but more studies
are still needed to confirm this and to evaluate the safety and efficacy of this combination.
Abreu et al. [14] reported signs of keratoconus progression in children implanted with ICRS
and followed more than 6 years. In keratoconus cases in children in whom their clinical
picture is more aggressive, the treatment must comprise three phases which are: prevent-
ing progression, regularizing the cornea, and rehabilitating vision. ICRS can contribute
to improving vision and regularize the cornea and defer or avoid a corneal transplant.
It should be considered that although corneal collagen cross-linking stops the progression
of keratoconus, visual impairment persists and ICRS can be a valid alternative with the
optimization of the femtosecond laser procedure to regularize the cornea, improve vision,
facilitate the fitting of contact lenses, and to avoid or defer corneal transplantation.
Author Contributions: Conceptualization, P.L. and D.P.P.; methodology, P.L. and D.T.; software,
D.T.; validation, P.L., P.L.J. and D.T.; formal analysis, D.P.P.; investigation, P.L, P.L.J., D.T. and
D.P.P.; resources, P.L.; data curation, P.L.; writing—original draft preparation, D.P.P.; writing—
review and editing, P.L. and D.P.P.; visualization, P.L., P.L.J., D.T. and D.P.P.; supervision, D.T.;
project administration, P.L.; funding acquisition, P.L. All authors have read and agreed to the
published version of the manuscript.
Funding: The author David P Piñero has been supported by the Ministry of Economy, Industry and
Competitiveness of Spain within the program Ramón y Cajal, RYC-2016-20471.
Institutional Review Board Statement: The study was approved by the Medical Ethics Committee
of Clinica Larco on July 2018.
Informed Consent Statement: Informed consent was obtained from all subjects involved in the study.
Data Availability Statement: Data available on request due to privacy restrictions.
Conflicts of Interest: The authors declare no conflict of interest.
Vision 2021, 5, 1 10 of 11
Abbreviations
The following abbreviations are used in this manuscript:
SD standard deviation
D diopters
UDVA uncorrected distance visual acuity
CDVA corrected distance visual acuity
K1 flattest keratometric reading
KM mean keratometric reading
CCT central corneal thickness
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